Within this group, there was one patient that could be classified as CHIP and three patients had <3% JAK2 V617F allele burden but did not have MPN, while one patient was diagnosed with chronic myelogenous leukemia (CML). Here, JAK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.